General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Acorda Therapeutics Announces Delisting from Nasdaq | businesswire.com • |
Acorda Therapeutics Announces Nasdaq Delisting Notification | businesswire.com • |
Why Is Acorda Therapeutics (ACOR) Stock Down 72% Today? | investorplace.com • |
Acorda Therapeutics shares sink nearly 40% after bankruptcy filing | marketwatch.com • |
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement | businesswire.com • |
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 | businesswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | 0 | N/A | N/A | N/A |
2024-04-01 | 2023-12 | 0 | N/A | N/A | N/A |
2023-11-13 | 2023-09 | 0 | N/A | N/A | N/A |
2023-08-08 | 2023-06 | 0 | N/A | N/A | N/A |
2023-05-11 | 2023-03 | 0 | N/A | N/A | N/A |
2023-03-09 | 2022-12 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-03-02 | BLANK BURKHARD | Officer | 18.53K | Stock Award(Grant) |
2023-03-16 | COHEN RON | Chief Executive Officer | 149.76K | Purchase |
2018-05-20 | GREENE BARRY E | Director | 1.27K | Conversion of Exercise of derivative security |
2019-03-07 | HINDMAN ANDREW ASA | Officer | 15.64K | Stock Award(Grant) |
2020-09-16 | LAWRENCE DAVID W | Officer | 15.98K | Stock Award(Grant) |
2018-11-25 | RANDALL LORIN J | Director | 0.00 | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Davidson Kempner Partners | 90.15K | 1.06M | 7.26% |
2023-06-29 | Davidson Kempner Capital Management LP | 55.15K | 717.44K | 4.44% |
2023-06-29 | Renaissance Technologies, LLC | 45.56K | 592.75K | 3.67% |
2023-06-29 | Acadian Asset Management. LLC | 34.13K | 444.04K | 2.75% |
2023-06-29 | Blackrock Inc. | 6.78K | 88.16K | 0.55% |
2022-12-30 | Telemetry Investments, L.L.C. | 6.63K | 101.59K | 0.53% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 7.99K | 103.94K | 0.64% |
2023-05-30 | Fidelity Extended Market Index Fund | 6.70K | 80.40K | 0.54% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 3.84K | 49.91K | 0.31% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.42K | 17.08K | 0.11% |
2023-05-30 | Fidelity Total Market Index Fund | 520.00 | 6.24K | 0.04% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 389.00 | 4.83K | 0.03% |
Split | Date |
---|---|
1 : 20 | 2023-06-05 |
1 : 6 | 2021-01-04 |
She’s getting her 2nd wind!
Wall gone!
Huge wall at .6674, take it out an we gone!!
I remember being into this shitty stock for so much. Thank God I got out and you can too. This is a horrible company and you’ll never see profits
Buy IDEX ITS it’s going to big run
️ guys
Patent awarded!
Isn’t it expected to jump after seeing its earnings ? Is it wise to hold till tomorrow.
$AIKI guys. Cancer drug news today. Will likely pop more tomorrow.
Annnddd here come the dumpers
Sigh wtf man